Rebecca A. Sosa

Dr. Rebecca A. Sosa


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Journal of Hepatology
Verified
Journal Article
Closed access
KNKojiro Nakamura
Kojiro Nakamura
MZMin Zhang
Min Zhang
SKShoichi Kageyama
Shoichi Kageyama
BKBibo Ke
Bibo Ke
TFTakehiro Fujii
Takehiro Fujii
JKJerzy W. Kupiec-Weglinski
Jerzy W. Kupiec-Weglinski

8 December 2016 in JCI Insight
Verified
Journal Article
Open access
PDF file
RSRebecca A. Sosa
Rebecca A. Sosa
AZAli Zarrinpar
Ali Zarrinpar
MRMaura Rossetti
Maura Rossetti
CLCharles R. Lassman
Charles R. Lassman
BNBita V. Naini
Bita V. Naini
ERElaine F. Reed
Elaine F. Reed
BACKGROUND. Orthotopic liver transplant (OLT) is the primary therapy for end-stage liver disease and acute liver failure. However, ischemia/reperfusion injury (IRI) can severely compromise allograft survival. To understand the evolution of immune responses underlying OLT-IRI, we evaluated longitudinal cytokine expression profiles from adult OLT recipients before transplant through 1 month after transplant. METHODS. We measured the expression of 38 cytokines, chemokines, and growth factors in preoperative and postoperative recipient circulating systemic blood (before transplant and 1 day, 1 week, and 1 month after transplant) and intraoperative portal blood (before and after reperfusion) of 53 OLT patients and analyzed this expression in relation to biopsy-proven IRI ( n = 26 IRI+; 27 IRI–), clinical liver function tests early (days 1–7) after transplant, and expression of genes encoding cytokine receptors in biopsies of donor allograft taken before and after reperfusion. RESULTS. Bilirubin and arginine transaminase levels early after transplant correlated with IRI. Fourteen cytokines were significantly increased in the systemic and/or portal blood of IRI+ recipients that shifted from innate to adaptive-immune responses over time. Additionally, expression of cognate receptors for 10 of these cytokines was detected in donor organ biopsies by RNAseq. CONCLUSION. These results provide a mechanistic roadmap of the early immunological events both before and after IRI and suggest several candidates for patient stratification, monitoring, and treatment. FUNDING. Ruth L. Kirschstein National Research Service Award T32CA009120, Keck Foundation award 986722, and a Quantitative & Computational Biosciences Collaboratory Postdoctoral Fellowship.

10 August 2021 in Hepatology
Verified
Journal Article
Closed access
MNMing Ni
Ming Ni
JZJing Zhang
Jing Zhang
RSRebecca A. Sosa
Rebecca A. Sosa
HZHanwen Zhang
Hanwen Zhang
HWHan Wang
Han Wang
YZYuan Zhai
Yuan Zhai

30 October 2020 in Hepatology
Verified
Journal Article
Closed access
RSRebecca A. Sosa
Rebecca A. Sosa
ATAllyson Q. Terry
Allyson Q. Terry
FKFady M. Kaldas
Fady M. Kaldas
YJYi‐Ping Jin
Yi‐Ping Jin
MRMaura Rossetti
Maura Rossetti
ERElaine F. Reed
Elaine F. Reed

14 November 2017 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
KNKojiro Nakamura
Kojiro Nakamura
SKShoichi Kageyama
Shoichi Kageyama
SYShi Yue
Shi Yue
JHJing Huang
Jing Huang
TFTakehiro Fujii
Takehiro Fujii
JKJerzy W. Kupiec-Weglinski
Jerzy W. Kupiec-Weglinski
Liver ischemia–reperfusion injury (IRI) represents a major risk factor of early graft dysfunction and a key obstacle to expanding the donor pool in orthotopic liver transplantation (OLT). Although graft autophagy is essential for resistance against hepatic IRI, its significance in clinical OLT remains unknown. Despite recent data identifying heme oxygenase‐1 (HO‐1) as a putative autophagy inducer, its role in OLT and interactions with sirtuin‐1 (SIRT1), a key autophagy regulator, have not been studied. We aimed to examine HO‐1–mediated autophagy induction in human OLT and in a murine OLT model with extended (20 hours) cold storage, as well as to analyze the requirement for SIRT1 in autophagy regulation by HO‐1. Fifty‐one hepatic biopsy specimens from OLT patients were collected under an institutional review board protocol 2 hours after portal reperfusion, followed by Western blot analyses. High HO‐1 levels correlated with well‐preserved hepatocellular function and enhanced SIRT1/LC3B expression. In mice, HO‐1 overexpression by genetically modified HO‐1 macrophage therapy was accompanied by decreased OLT damage and increased SIRT1/LC3B expression, whereas adjunctive inhibition of SIRT1 signaling diminished HO‐1–mediated hepatoprotection and autophagy induction. Our translational study confirms the clinical relevance of HO‐1 cytoprotection and identifies SIRT1‐mediated autophagy pathway as a new essential regulator of HO‐1 function in IR‐stressed OLT.

24 August 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
RSRebecca A. Sosa
Rebecca A. Sosa
CMCathi Murphey
Cathi Murphey
RRRachel R. Robinson
Rachel R. Robinson
TFThomas G. Forsthuber
Thomas G. Forsthuber
Evidence has suggested both a pathogenic and a protective role for the proinflammatory cytokine IFN-γ in experimental autoimmune encephalomyelitis (EAE). However, the mechanisms underlying the protective role of IFN-γ in EAE have not been fully resolved, particularly in the context of CNS antigen-presenting cells (APCs). In this study we examined the role of IFN-γ in myelin antigen uptake by CNS APCs during EAE. We found that myelin antigen colocalization with APCs was decreased substantially and that EAE was significantly more severe and showed a chronic-progressive course in IFN-γ knockout (IFN-γ−/−) or IFN-γ receptor knockout (IFN-γR−/−) mice as compared with WT animals. IFN-γ was a critical regulator of phagocytic/activating receptors on CNS APCs. Importantly, “free” myelin debris and lipid peroxidation activity at CNS lesions was increased in mice lacking IFN-γ signaling. Treatment with N-acetyl-l-cysteine, a potent antioxidant, abolished lipid peroxidation activity and ameliorated EAE in IFN-γ–signaling-deficient mice. Taken together the data suggest a protective role for IFN-γ in EAE by regulating the removal of myelin debris by CNS APCs and thereby limiting the substrate available for the generation of neurotoxic lipid peroxidation products.